[Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus ) strain Moscow].
G A KudrovS S ZainutdinovAntonina A GrazhdantsevaA V ShipovalovGalina SivolobovaA V SemenovaIuliia A MerkulevaDmitriy N ShcherbakovOleg Svyatoslavovich TaranovAnna Vladimirovna ZaykovskayaI S ShulginaOleg V PyankovGalina V KochnevaPublished in: Voprosy virusologii (2023)
Sen-RBDdelta(M) is a promising vaccine construct against SARS-CoV-2 infection and has a protective properties even after a single intranasal introduction.